Contact allergy, irritancy and 'danger'

Contact Dermatitis

Volumn 42, Issue 3, 2000, Pages 123-127

  McFadden, J P ^a   Basketter, D A ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

Contact allergy; Danger signals; Immunological mechanism of contact dermatitis; Irritants; Prevention; Tolerance

Indexed keywords

HAPTEN; TUMOR NECROSIS FACTOR ALPHA;

CONCENTRATION RESPONSE; CONTACT ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; OCCUPATIONAL ECZEMA; REVIEW; SENSITIZATION; SKIN ALLERGY;

ALLERGENS; DERMATITIS, ALLERGIC CONTACT; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033970650     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2000.042003123.x     Document Type: Review

References (45)

1. 1. Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 1994: 12: 991-1045.
2. 2. Matzinger P. An innate sense of danger. Sem Immunol 1998: 10: 399-415.
3. 3. Nilzen A, Wikström K. The influence of lauryl sulphate on the sensitisation of guinea pigs to chrome and nickel. Acta Dermato-venereologica 1955: 35: 292-298.
4. 4. McLelland J, Shuster S, Matthews J N S. 'Irritants' increase the response to an allergen in allergic contact dermatitis. Arch Dermatol 1991: 127: 1016-1019.
5. 5. Basketter D A. Guinea pig predictive test for contact hypersensitivity. In: Dean J, Munson A, Luster M, Kimer I (eds). Immunotoxicology and immunopharmacology. New York: Raven Press, 1994: 693-702.
6. 6. Skog M I. Measurement and differentiation of the cellular infiltrate in experimental toxic contact dermatitis. Acta Dermato-venereologica 1980: 60: 239-244.
7. 7. Willis C M, Young E, Brandon D R, Wilkinson J D. Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis. Br J Dermatol 1986: 115: 305-316.
8. 8. Enk A H, Katz S I. Early molecular events in the induction phase of contact sensitivity. Proceedings of the National Academy of Sciences of the USA 1992: 89: 1398-1402.
9. 9. Dearman R J, Cumberbatch M, Hilton J, Fielding I, Basketter D A, Kimber I. A reappraisal of the skin sensitizing activity of 2,4-dinitrothiocyanobenzene. Food and Chemical Toxicol 1997: 35: 261-269.
10. 10. Sikorski E E, Gerberick G F, Ryan C A, Miller C M, Ridder G M. Phenotypic analysis of lymphocyte subpopulations in lymph nodes draining the ear following exposure to contact allergens and irritants. Fundam Appl Toxicol 1996: 34: 25-35.
11. 11. Judge M R, Griffiths H A, Basketter D A, White I R, Rycroft R J G, McFadden J P. Variation in response of human skin to irritant challenge. Contact Dermatitis 1996: 34: 115-117.
12. 12. Basketter D A, Griffiths H A, Wang X M, Wilhelm K P, McFadden J P. Individual ethnic and seasonal variability in irritant susceptibility of skin: the implications for a predictive human patch test. Contact Dermatitis 1996: 35: 208-213.
13. 13. Robinson M K, Perkins M A, Basketter D A. Application of a 4 hour human patch test method for comparative and investigative assessment of skin irritation. Contact Dermatitis 1998: 38: 194-202.
14. 14. Hunziker T, Brab C U, Kapp A, Waelti E R, Braathen L R. Increased levels of inflammatory cytokines in human skin lymph from sodium lauryl sulphate-induced contact dermatitis. Br J Dermatol 1992: 127: 254-257.
15. 15. Lewis R W, McCall J C, Botham P A, Kimber I. Investigation of TNF alpha release as a measure of skin irritancy. Toxicology in Vitro 1993: 7: 393-395.
16. 16. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel J C, Luger T A. Human keratinocytes are a source for tumour necrosis factor alpha evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990: 172: 1609-1614.
17. 17. Groves R W, Allen M H, Ross E L, Barker J N, MacDonald D M. Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 1995: 132: 345-352.
18. 18. Cumberbatch M, Dearman R J, Kimber I. Langerhans cell requires signals from both TNF and IL-1 beta for migration. Immunology 1997: 92: 388-395.
19. 19. Koboyashi Y. Langerhans cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology 1997: 94: 496-501.
20. 20. Ioffreda M D, Whitaker D, Murphy G F. Mast cell degranulation upregulates alpha 6 integrins on epidermal Langerhans cells. J Invest Dermatol 1993: 101: 151-154.
21. 21. Cumberbatch M, Kimber I. Tumour necrosis factor is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitisation. Immunology 1995: 84: 31-35.
22. 22. Wang B, Fujisawa H, Zhuang L, Kondo S, Shivji G M, Kim C S, Mak T W, Sauder D N. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 1997: 159: 6148-6155.
23. 23. Grangsjo A, Leijdon-Kuligowski A, Torma H, Roomans GM, Lindberg M. Different pathways in irritant contact dermatitis? Contact Dermatitis 1996: 35: 355-360.
24. 24. Witmer-Pack M D, Olivier W, Vaklinsky J, Schuler G, Steinman R M. Granulocyte/marophage colony stimulating factor is essential for the viability and function of cultured murine epidermal langerhans cells. J Exp Med 1987: 166b: 1484-1498.
25. 25. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988: 167: 700-705.
26. 26. Picut C A, Lee C S, Dougherty E P, Anderson K L, Lewis R M. Immunostimulatory capabilities of highly enriched langerhans cells in vitro. J I Dermatol 1988: 90: 201-206.
27. 27. White S J, Friedmann P S, Moss C, Simpson J M. The effect of altering area of application and dose per unit area on sensitisation to DNCB. Br J Dermatol 1986: 115: 663-668.
28. 28. Heylings J R, Clowes H M, Cumberbatch M, Dewarman R J, Kimber I, Hopkins S J. Sensitization to 2,4-dinitrochlorobenzene influence of vehicle on absorption and lymph node activation. Toxicology 1996: 109: 57-65.
29. 29. Kligman A M. The identification of contact allergens by human assay II Factors influencing the induction and measurement of allergic contact dermatitis. J Invest Dermatol 1966: 47: 375-392.
30. 30. Magnusson B, Kligman A M. Allergic contact dermatitis in the guinea pig. Springfield, Ilinois: Charles C. Thomas, 1970.
31. 31. Cumberbatch M, Scott R C, Basketter D A, Scholes E W, Hilton J, Dearman R J, Kimber I. Influence of sodium lauryl sulphate on 2,4 dinitrochlorobenzene-induced lymph node activation. Toxicology 1993: 77: 181-191.
32. 32. Smith H R, Holloway D, Armstrong D K B, Basketter D A, McFadden J P. Irritant thresholds in subjects with colophony allergy. Contact Dermatitis 1999: 41: in press.
33. 33. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunology Today 1998: 19: 37-44.
34. 34. Barker J N, Mitra R S, Griffiths C E, Dixit V M, Nickoloff B J. Keratinocytes as initiators of inflammation. Lancet 1991: 337: 211-214.
35. 35. Grabbe S, Steinert M, Mahuke K, Schwarz A, Luger T A, Schwarz T. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. J Clin Invest 1996: 98: 1158-1164.
36. 36. Allenby C F, Basketter D A. An arm immersion model of compromised skin (II). Influence on minimal eliciting patch test concentrations of nickel. Contact Dermatitis 1993: 28: 129-133.
37. 37. Angelini G, Rigano L, Foti C, Veña G A, Grandolfo M. Contact allergy to impurities in surfactants: amount, chemical structure and carrier effect in reactions to 3-dimethylaminopropylameine. Contact Dermatitis 1996: 34: 248-252.
38. 38. Healy J I, Goodmoor C C. Positive versus negative signalling by lymphocyte antigen receptor. Annu Rev Immunol 1998: 16: 645-670.
39. 39. Steinbrunk K, Sorg C, Macher E. Low dose tolerance to contact allergens in mice: a functional role for CD8+ T helper 2 cells. J Exp Med 1996: 183: 759-768.
40. 40. Asherson G L, Perera M A C, Thomas W R. Contact sensitivity and the DNA response in mice to high and low doses of oxazolone: low dose unresponsiveness following painting and feeding and its prevention by pretreatment with cyclophosphamide. Immunology 1979: 36: 449-459.
41. 41. Sy M S, Miller S D, Claman H N. Immune supression with supraoptimal doses of antigen in contact sensitivity 1 Demonstration of supressor cells and their sensitivity to cyclophosphamide. J Immunol 1977: 119: 240-244.
42. 42. Lowney E D. Topical hyposensitisation of allergic contact sensitivity in the guinea pig. J Invest Dermatol 1964: 43: 487-490.
43. 43. Lowney E D. Imunologic unresponsiveness appearing after topical application of contact sensitizers to the guinea pig. J Immunol 1965: 95: 397-403.
44. 44. Lowney E D. Simultaneous development of unresponsiveness and of sensitivity following topical exposure of contact sensitizers. J Invest Dermatol 1967: 48: 391-398.
45. 45. Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF strategies to neutralise this proinflammatory cytokine. Immunol Today 1998: 18: 487-492.